Chimerix Inc (NASDAQ:CMRX)
| 10.61 Delayed Data As of 3:59pm ET |  +0.65 / +6.53%Today’s Change | 1.19 Today|||52-Week Range 11.57 | +119.67% Year-to-Date |
Latest CMRX News | Press Releases
| Chimerix (CMRX) Q4 2020 Earnings Call Transcript Feb 25 / MotleyFool.com - Paid Partner Content | Steven Cohen Dives Into Chimerix Feb 24 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 9.96 |
| Today’s open | 10.02 |
| Day’s range | 9.94 - 10.73 |
| Volume | 27,324 |
| Average volume (3 months) | 919,426 |
| Market cap | $842.2M |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | +65.49% |
| Earnings growth (this year) | -2.38% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -57.09% |
| P/E ratio | NM |
| Price/Sales | 55.91 |
| Price/Book | 8.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMPHAmphastar Pharmaceut... | -0.08 | -0.46% |
| PRVBProvention Bio Inc | -0.55 | -4.28% |
| ---- | ||
| AERIAerie Pharmaceutical... | +0.61 | +3.18% |
Data as of 4:00pm ET, 03/02/2021
Financials
| Next reporting date | May 10, 2021 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $5.4M |
| Annual profit (last year) | -$43.5M |
| Net profit margin | -810.16% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
